Clinical Trial Update: Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the combined effect of sitagliptin and an ACE inhibitor on blood pressure in people with metabolic syndrome and hypertension; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• ACE inhibitor (unspecified)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Vanderbilt University | Conditions: Metabolic Syndrome, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-05-11